On October 28, 2024, the Foundation for Sarcoidosis Research hosted the Externally-Led Patient Focused Drug Development Meeting (EL-PFDD), an interactive, virtual, public meeting that provided patients and caregivers a unique opportunity to share about their unmet needs, the quality of life impacts of sarcoidosis, and preferences in respect to symptom management and the development of new therapies.
